Claris Lifesciences Ahmedabad

Claris worked towards creating a niche in a highly-regulated business. Over a history of 17 years, we created nearly a billion-dollar valuation, with establishing world-class integrated business model that helped garner several stringent international regulatory approvals, including US FDA, MHRA (UK), TGA (Australia), MCC (South Africa), ANVISA (Brasil), INVIMA (Colombia), and GCC FDCA. Claris also entered a Joint Venture (JV) in August 2013 with Japanese companies Otsuka Pharmaceutical Factory, Inc. and Mitsui & Co. Ltd. for its Infusion business in India & emerging markets, selling 80% stake and creating JV company Claris Otsuka Private Limited (COPL). Claris has completed the sale of its remaining stake to Otsuka, and exited from the JV. Coupled with the strength of technical know-how & professional expertise, Claris growth escalated through the diligent work carried out by the members to take the organisation to newer heights year-on-year. This proficiency was reconfirmed through the consecutive 8 wins as one of India's Best Companies To Work For and one of the best companies in Healthcare industry by The Economic Times and Great Place to Work Institute, India. Parallel to striving for excellence, Claris serves as a socially responsible organisation, fulfilling goals beyond the business commitments. Hence, we always support and encourage various social causes aimed at promoting sports, health, education, and culture encompassing the broader spectrum of the society.

Active/Inactive	Active
CIN	L85110GJ1994PLC022543
Office Location	Ahmedabad, Gujrat, India
Incorporation Year	1999(25 yrs old)
Industry	Hospitals & Healthcare
Company Employees	1001-5000
Website	http://clarislifesciences.com
Avg Revenue	$ 50M - 100M
Phone Number	91 7926563331
Social Profile